Login
$NVST
$24.03 +$0.00 (0.0%) After hours

$NVST SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G
12 Nov 2026 PROSPECTUS
10 Nov 2026 FREE WRITING PROSPECTUS
10 Nov 2026 PROSPECTUS
09 Nov 2026 REGISTRATION STATEMENT
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

BREA, Calif., November 4, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended October 2, 2026.

02 Nov 2026 Form 4: Keel Paul A, Director

Gave up 54,197 shares to cover exercise price or tax ($1.27M)

27 Oct 2026 8-K: Regulation FD Disclosure

BREA, Calif., October 27, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced the publication of its 2025 Sustainability Report. The report provides an update on Envista’s progress in expanding acce...

17 Sep 2026 8-K: Regulation FD Disclosure

On September 17, 2026, Envista Holdings Corporation (the "Company") will host its 2026 Investor Day, during which members of the Company's executive leadership team will provide an overview of the Company's strategy, growth initiatives, ...

27 Aug 2026 Form 4: Acurio Veronica, President, Orthodontics

Gave up 7,710 shares to cover exercise price or tax ($212K)

27 Aug 2026 Form 4: Befidi Robert, President, Diagnostics

Gave up 5,147 shares to cover exercise price or tax ($141K)

27 Aug 2026 Form 4: Hammes Eric D., Chief Financial Officer

Gave up 10,885 shares to cover exercise price or tax ($299K)

27 Aug 2026 Form 4: Nilsson Stefan, President, Nobel Biocare

Gave up 804 shares to cover exercise price or tax ($22.1K)

24 Aug 2026 Form 4: Reis Mischa, SVP, Strategy & Bus. Dev.

Sold 8,000 shares ($220K)

20 Aug 2026 Form 4: Keel Paul A, Director

Received 179,730 shares as a grant or award · Granted 159,900 Performance Share Unit

20 Aug 2026 Form 4: Hammes Eric D., Chief Financial Officer

Granted 47,970 Performance Share Unit

20 Aug 2026 144
19 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

Reference is made to the information contained in Item 8.01 of this Current Report on Form 8-K, disclosing the Company’s Board of Directors’ appointment of Paul Keel, the Company’s President and Chief Executive Officer, to the role of Ch...

13 Aug 2026 Form 3: Thomas Coree K., CAO

Holds 5,814 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support